Opinion of the Head of Psychedelic Research
The head of psychedelic research, Dr. Robin Carhart-Harris notes that this drug seems to have a resetting effect on the brain.
Psilocybin might be giving these participants the temporary and necessary kickstart in order to break out of the depressive states, and the imaging results support a reset analogy.
It is crucial to note that this study was made in regulated environment by professionals. The researchers warn people to not self-medicate since there is no guarantee that the same results will occur.
Also, 19 participants are not enough in order to validate an efficient treatment method. It is like that because there was no control group to compare the effects of this active compound.
According to the senior author of the paper, David Nutt larger studies are necessary to see if this effect which is positive might occur in more people. However, these findings provide another treatment to explore.
In order to better understand the role which the drug has in relieving the depression symptoms, the researchers will begin a new trail to compare psilocybin with a well-known antidepressant early next year.
If you find this article useful, share it with your friends and family.
